scholarly journals Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Takeshi Horii ◽  
Koichiro Atsuda
Keyword(s):  
Type 2 Diabetes ◽  
Pharmacist Intervention

scholarly journals Impact of Pharmacist Intervention on Improving the Quality of Life of Patients with Type 2 Diabetes Mellitus

2019 ◽  
Vol 7 (8) ◽  
pp. 1401-1405 ◽  
Author(s):  
Shofian Syarifuddin ◽  
Azizah Nasution ◽  
Aminah Dalimunthe ◽  
Khairunnisa
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pharmacist Intervention ◽  
Disease Stage ◽  
The Mean ◽  
The Impact

AIM: To analyse the characteristics, and analyse the impact of pharmacist intervention on quality of life (QOL) outpatients with type 2 diabetes mellitus (T2DM). METHODS: This six-month analytical cohort study was conducted by assessing the patients’ characteristics and their quality of life by distributing a questionnaire, and the 36-Item short form instrument to the patients with T2DM (n = 45) admitted to the Tertiary hospital in Tebing Tinggi. Patients who had mental disorders, HIV-AIDS, liver disease, stage 4 chronic kidney disease, and pregnant women were excluded from the study. The patients’ quality of life was measured before and after interventions and analysed using the paired t-test. All analyses were performed using the Statistical Package for the Social Sciences (SPSS, version 22, Chicago, IL, USA) (p < 0.05 was considered significant). RESULTS: The mean age of the patients was 61.96 ± 6.45 (years). Most (66.7%) of them were females. The mean QOL (in the score) of the patients: before the intervention, 61.07 ± 15.13; after the intervention, 70.15 ± 14.23, there was a significant difference between groups with and without interventions, p < 0.001. CONCLUSION: Active contribution of pharmacists in the management of T2DM patients is urgent and important to improve the patients’ QOL.

An employer-based, pharmacist intervention model for patients with type 2 diabetes

2010 ◽  
Vol 67 (4) ◽  
pp. 312-316 ◽  
Author(s):  
Ravi Iyer ◽  
Pauline Coderre ◽  
Theresa McKelvey ◽  
Jason Cooper ◽  
Jan Berger ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pharmacist Intervention ◽  
Intervention Model

scholarly journals Pharmacists Intervention Reduced Drug-Related Problems in the Treatment of Patients with Type 2 Diabetes Mellitus

2019 ◽  
Vol 7 (22) ◽  
pp. 3856-3860
Author(s):  
Azizah Nasution ◽  
Aminah Dalimunthe ◽  
Khairunnisa Khairunnisa
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Usual Care ◽  
Pharmacist Intervention ◽  
Antidiabetic Drugs ◽  
Drug Related Problems ◽  
Significant Difference ◽  
The Impact

BACKGROUND: Type 2 Diabetes Mellitus (T2DM) remains as a global public health problem, including Indonesia due to its continuous increasing prevalence. AIM: To analyze the impact of pharmacist intervention on drug-related problems (DRPs) occurred in the management of patients with T2DM admitted to Tebing Tinggi Hospital (TTH), Indonesia, period March through August 2018. METHODS: This six-month retrospective prospective cohort study evaluated the impact of pharmacist intervention on the occurrence of DRPs in the management of patients with T2DM (n = 45) insured by Social Security Organizing Body in TTH, North Sumatera, Indonesia. The inclusion criteria were T2DM patients with age ≥ 18 years and under treatment of antidiabetic drugs. A questionnaire was used to assess the characteristics of the patients and antidiabetic drugs provided. The incidence of DRPs in groups with usual care for the previous three-month and with pharmacist interventions for the next three-month admissions were analyzed using Pharmaceutical Care Network Europe (PCNE) DRP classification system version 8.01 that consists of 3 primary domains for problems, 8 primary domains for causes, and 5 primary domains (PCNE, 2017) and trustable literatures. The obtained data were analyzed using descriptive statistics and paired t test in the program of Statistical Package for the Social Sciences version 19 (p < 0.05 was considered significant). RESULTS: Most (66.7%) of the patients were female. Their mean age was 61.96 ± 6.45 (years). The three most widely provided drugs were metformin, glimepirid, and gliclazide. Total incidence of DRPs in groups with: usual care, 128; intervention, 39. There was a significant difference between the incidence of DRPs in groups with usual care and intervention, p ≤ 0.001. CONCLUSION: Pharmacist intervention reduced the incidence of DRPs in the management of T2DM patients.

Impact of a Clinical Pharmacist Intervention Program on the Follow-up of Type-2 Diabetic Patients

2020 ◽  
pp. 001857872097388
Author(s):  
Abdel-Hameed I. Ebid ◽  
Mohamed A. Mobarez ◽  
Ramadan A. Ramadan ◽  
Mohamed A. Mahmoud
Keyword(s):  
Type 2 Diabetes ◽  
Usual Care ◽  
Clinical Pharmacist ◽  
Usual Care Group ◽  
Intervention Group ◽  
Pharmacist Intervention ◽  
Care Group ◽  
Clinical Pharmacist Intervention

Aims: The primary aim of this current study was to investigate the impact of the clinical pharmacist interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes in Egypt. Methods: A prospective trial was conducted on 100 patients with uncontrolled type 2 diabetes admitted in the diabetes outpatient’s clinics. Patients were randomly allocated into the clinical pharmacist intervention group and usual care group. In the intervention group, the clinical pharmacist, in collaboration with the physician had their patients receive pharmaceutical care interventions. In contrast, the usual care group patients received routine care without clinical pharmacist’s interference. Results: After 6-month of follow-up, of the average HbA1c and FBG values of the patients in the clinical pharmacist intervention group (HbA1c % from 8.6 to 7.0; FBG (mg/dL) from 167.5 to 121.5) decreased significantly compared to the usual care group patients (HbA1c % from 8.1 to 7.8; FBG (mg/dL) from 157.3 to 155.9) ( P < .05). Additionally, the results indicated that mean scores of patients ‘diabetes knowledge, medication adherence, and diabetes self-care activities of the patients in the clinical pharmacist group increased significantly compared to the control group ( P < .05). Conclusions: The study demonstrated an improvement in HbA1c, FBG, and lipid profile, in addition to self-reported medication adherence, diabetes knowledge, and diabetes self-care activities in patients with type 2 diabetes who received pharmaceutical care interventions. The study outcomes support the benefits and the need to integrate clinical pharmacist interventions in the multidisciplinary healthcare team in Egypt.

scholarly journals Impact of pharmacist intervention on glycemic control of type 2 diabetes patients in a tertiary care hospital

2021 ◽  
Author(s):  
Kamelia Sadeghi ◽  
Karanesh Dass ◽  
Shobha Hiremath ◽  
Swapna Bhaskar
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Standard Treatment ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Pharmacist Intervention ◽  
Care Hospital ◽  
The Impact

Objective: Diabetes is one of the most common chronic disease that requires comparatively more care to achieve optimal therapeutic outcomes. The aim of this study was to study the impact of pharmacist intervention on glycemic control of type 2 diabetes patients in a tertiary care hospital. The objectives were: To assess the parameters of glycemic control namely FBS, PPBS, and HbA1c; To provide patient education to one group of patients while other group of patients get standard care; To assess the impact of the educational intervention on blood sugar levels and HbA1c. Materials and methods: It was hospital based prospective interventional study carried out in the general medicine out-patient department of St. Philomena’s hospital, a tertiary care hospital, in Bangalore, India. The patients recruited were divided equally and randomly into control and intervention groups. Patients in the interventional group received patient informational leaflets, and education in addition to standard treatment, while the control group patients received only standard treatment. Parameters of glycemic control namely FBS, PPBS, and HbA1c of the patients were measured at baseline and at the end of the follow up period of 3 months and compared using appropriate statistical tests. Result: 50 patients having HbA1c value of >8% were included in the study. FBS, PPBS, and HbA1c values of all patients were measured at baseline and compared to the values obtained at the end of the follow up period, and was found to be statistically significant (p < 0.05). The difference in the baseline and follow up values between the control and intervention groups was also compared and found to be statistically significant (p< 0.05). Conclusion: It was observed from our study that pharmacist led educational intervention program for the management of type 2 diabetes had a positive impact in lowering the levels of glycemic parameter.

Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan

2020 ◽  
Author(s):  
Takeshi Horii ◽  
Koichiro Atsuda
Keyword(s):  
Type 2 Diabetes ◽  
Hospital Admission ◽  
Symptomatic Treatment ◽  
Pharmacist Intervention ◽  
Pharmacy Service ◽  
Drug Costs ◽  
Clinical Ward ◽  
Inappropriate Medications ◽  
Objective Investigation

Abstract Objective Investigation of polypharmacy in patients with type 2 diabetes revealed that the medications being administered according to the patient’s symptoms and complaints strongly contributed to polypharmacy. We explored the effects of clinical ward pharmacy service, which evaluated the need for symptomatic treatment, therefore minimizing polypharmacy by reducing inappropriate medications. Results The number of drugs [hospitalization vs. discharge: 9 (1-17) vs. 7 (1-16), P < 0.001] and rate of PP (hospitalization vs. discharge: 75.4% vs. 61.1%, P < 0.001) were significantly lower at discharge. Since hospital admission, the number of drugs increased (n = 6, 11%), remained unchanged (n = 15,28%), decreased by 1 drug (n = 4,8%), decreased by 2 drugs (n = 3,6%), and decreased by more than 2 drugs (n = 25,5%). Daily drug costs were significantly reduced (hospitalization vs. discharge: ＄8.3 vs. ＄6.1, P < 0.001).

Sign in / Sign up

Export Citation Format

Share Document